These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 7908218)

  • 1. Allelic loss on distal chromosome 17p is associated with poor prognosis in a group of Brazilian breast cancer patients.
    Nagai MA; Pacheco MM; Brentani MM; Marques LA; Brentani RR; Ponder BA; Mulligan LM
    Br J Cancer; 1994 Apr; 69(4):754-8. PubMed ID: 7908218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas.
    Andersen TI; Gaustad A; Ottestad L; Farrants GW; Nesland JM; Tveit KM; Børresen AL
    Genes Chromosomes Cancer; 1992 Mar; 4(2):113-21. PubMed ID: 1373310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of genetic alterations related to the development and progression of breast carcinoma.
    Nagayama K; Watatani M
    Jpn J Cancer Res; 1993 Nov; 84(11):1159-64. PubMed ID: 7903963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic alterations on chromosome 17 in human breast cancer: relationships to clinical features and DNA ploidy.
    Watatani M; Nagayama K; Imanishi Y; Kurooka K; Wada T; Inui H; Hirai K; Ozaki M; Yasutomi M
    Breast Cancer Res Treat; 1993 Dec; 28(3):231-9. PubMed ID: 7912561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed deletion mapping in sporadic breast cancer at chromosomal region 17p13 distal to the TP53 gene: association with clinicopathological parameters.
    Seitz S; Poppe K; Fischer J; Nothnagel A; Estévez-Schwarz L; Haensch W; Schlag PM; Scherneck S
    J Pathol; 2001 Jul; 194(3):318-26. PubMed ID: 11439364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of allelic loss on chromosome 17 in sporadic breast carcinomas detected by fluorescent-labeled microsatellite analysis.
    Niederacher D; Picard F; van Roeyen C; An HX; Bender HG; Beckmann MW
    Genes Chromosomes Cancer; 1997 Mar; 18(3):181-92. PubMed ID: 9071571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of 17p loss in gastric carcinoma using polymerase chain reaction.
    Kim CJ; Kim WH; Kim CW; Lee JB; Lee CK; Kim YL
    Lab Invest; 1995 Feb; 72(2):232-6. PubMed ID: 7853854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis.
    Leenstra S; Bijlsma EK; Troost D; Oosting J; Westerveld A; Bosch DA; Hulsebos TJ
    Br J Cancer; 1994 Oct; 70(4):684-9. PubMed ID: 7917918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification and protein over-expression of the neu/HER-2/c-erbB-2 protooncogene in human breast carcinomas: relationship to loss of gene sequences on chromosome 17, family history and prognosis.
    Børresen AL; Ottestad L; Gaustad A; Andersen TI; Heikkilä R; Jahnsen T; Tveit KM; Nesland JM
    Br J Cancer; 1990 Oct; 62(4):585-90. PubMed ID: 1977466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers.
    Tokunaga E; Okada S; Yamashita N; Akiyoshi S; Kitao H; Morita M; Kakeji Y; Maehara Y
    Breast Cancer; 2012 Apr; 19(2):161-9. PubMed ID: 21063923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of heterozygosity at chromosome 17p is associated with HER-2 amplification and lack of nodal involvement in breast cancer.
    Knyazev PG; Imyanitov EN; Chernitsa OI; Nikiforova IF
    Int J Cancer; 1993 Jan; 53(1):11-6. PubMed ID: 8416194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of loss of heterozygosity at loci on chromosome 17p13.3-ter in sporadic breast cancer is evidence for a putative tumour suppressor gene.
    Liscia DS; Morizio R; Venesio T; Palenzona C; Donadio M; Callahan R
    Br J Cancer; 1999 May; 80(5-6):821-6. PubMed ID: 10360661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Amplification of the erbb-2 (Her-2/NEU), erbb-1 (HER-1) and c-myc oncogenes is often combined with the deletion of the short arm of chromosome 17 in human carcinoma].
    Imianitov EN; Chernitsa OI; Nikiforova IF; Serova OM; Sokolov SI; Laur OIu; Togo AV; Kniazev PG
    Mol Biol (Mosk); 1993; 27(4):888-94. PubMed ID: 8103188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for a second tumor suppressor gene on 17p linked to high S-phase index in primary human breast carcinomas.
    Merlo GR; Venesio T; Bernardi A; Cropp CS; Diella F; Cappa AP; Callahan R; Liscia DS
    Cancer Genet Cytogenet; 1994 Sep; 76(2):106-11. PubMed ID: 7923057
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity in bilateral breast cancer.
    Kollias J; Man S; Marafie M; Carpenter K; Pinder S; Ellis IO; Blamey RW; Cross G; Brook JD
    Breast Cancer Res Treat; 2000 Dec; 64(3):241-51. PubMed ID: 11200774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity is detected at chromosomes 1p35-36 (NB), 3p25 (VHL), 16p13 (TSC2/PKD1), and 17p13 (TP53) in microdissected apocrine carcinomas of the breast.
    Lininger RA; Zhuang Z; Man Y; Park WS; Emmert-Buck M; Tavassoli FA
    Mod Pathol; 1999 Dec; 12(12):1083-9. PubMed ID: 10619258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer.
    Li X; Lee NK; Ye YW; Waber PG; Schweitzer C; Cheng QC; Nisen PD
    J Natl Cancer Inst; 1994 Oct; 86(20):1524-9. PubMed ID: 7932807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity at the TP53 gene: independent occurrence from genetic instability events in node-negative breast cancer.
    Lizard-Nacol S; Riedinger JM; Lizard G; Glasser AL; Coudray N; Chaplain G; Guerrin J
    Int J Cancer; 1997 Aug; 72(4):599-603. PubMed ID: 9259397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five distinct deleted regions on chromosome 17 defining different subsets of human primary breast tumors.
    Nagai MA; Medeiros AC; Brentani MM; Brentani RR; Marques LA; Mazoyer S; Mulligan LM
    Oncology; 1995; 52(6):448-53. PubMed ID: 7478429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.